![Panel: The future of the vaccines business](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2Fb31bd6da2d674fa7b1ef28aa40fd1bb2.png&q=0.8&m=fit&h=720)
![](https://img.swapcard.com/?u=https%3A%2F%2Fcdn-api.swapcard.com%2Fpublic%2Fimages%2Fb31bd6da2d674fa7b1ef28aa40fd1bb2.png&q=0.8&m=crop&h=720)
Panel: The future of the vaccines business
Wednesday, October 21, 2020 12:00 PM to 1:20 PM · 1 hr. 20 min. (Africa/Abidjan)
Plenary keynote
Information
- Pandemic responses: balancing act between public health responsibility and economic sustainability
- How can we keep vaccine research, development and delivery sustainable for global health and prioritize equity?
- How to approach infectious diseases, outbreaks and AMR pathogens that require considerable investment
- Financing and access around vaccine R&D, vaccine manufacturing and vaccine procurement
- Overview of global vaccine market and describing the characteristics of a healthy market (review of current frameworks)
- Insights from the introduction of new vaccines and strategies that have been leveraged to encourage sustainable, sufficient, relevant, predictable supply to meet demand – what’s worked and what hasn’t in different contexts, including LMICs
Session Type
Session Type
Plenary keynote